Italia markets open in 1 hour 9 minutes


LSE - LSE Prezzo differito. Valuta in USD.
Aggiungi a portafoglio
47,20-2,77 (-5,54%)
Alla chiusura: 05:14PM GMT
Schermo intero
Chiusura precedente49,97
Denaro0,00 x 0
Lettera0,00 x 0
Min-Max giorno50,24 - 50,41
Intervallo di 52 settimane50,24 - 50,41
Media VolumeN/D
Beta (5 anni mensile)0,91
Rapporto PE (ttm)24,82
EPS (ttm)1,90
Prossima data utili28 feb 2022 - 04 mar 2022
Rendimento e dividendo (forward)N/D (N/D)
Data ex dividendoN/D
Stima target 1AN/D
  • GlobeNewswire

    Dentsply Sirona and 3Shape Expand Their Strategic Partnership with Seamless Connectivity for Dentists and Dental Labs

    Dentsply Sirona’s intraoral Primescan and Omnicam scanners now integrate directly with 3Shape’s lab software, delivering better workflows and patient outcomes.CHARLOTTE, N.C., Dec. 08, 2021 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY). Dentsply Sirona and 3Shape have taken the next step according to their agreement and now provide a seamless and secure integration of Dentsply Sirona’s Connect Case Center with 3Shape’s Dental System software. Dentists using Primesca

  • GlobeNewswire

    Dentsply Sirona to Present at Upcoming Virtual Investor Conferences

    CHARLOTTE, N.C., Nov. 09, 2021 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY) - announced today that the Company will present at three upcoming investor conferences. Credit Suisse 30th Annual Healthcare Conference on November 11, 2021 at 4:20pm ETEvercore ISI 4th Annual HealthConX Conference on December 1, 2021 at 1:00pm ETPiper Sandler 33rd Annual Virtual Healthcare Conference on December 2, 2021 Webcast recording will be available on November 22, 2021 at 10:00am ET

  • GlobeNewswire

    Dentsply Sirona Reports Third Quarter 2021 Results

    Revenue increased 19.4% to $1,069 million. Organic revenue increased 21.1%GAAP EPS increased to $0.47 vs $0.25 in 2020Non-GAAP EPS increased to $0.68 vs $0.67 in 2020GAAP operating income increased to $159 million vs $82 million in 2020Non-GAAP operating income increased to $216 million vs $197 million in 2020Operating cash flow decreased to $172 million vs $207 million in 2020FY21 Non-GAAP EPS outlook range raised to $2.87 to $2.92 CHARLOTTE, N.C., Nov. 04, 2021 (GLOBE NEWSWIRE) -- DENTSPLY SIR